Abstract Background In December 2019, a novel coronavirus disease (COVID-19) emerged
in Wuhan, China, with an incredible contagion rate. However, the vertical transmission of …

Background Since the beginning of the novel coronavirus (SARS-CoV-2) disease outbreak,
there has been an increasing interest in finding a potential therapeutic agent for the disease …

The SARS-CoV-2 genome has undergone several mutations since the beginning of the
pandemic in December 2019. A number of these mutants were associated with higher …

A newly diagnosed coronavirus in 2019 (COVID-19) has affected all human activities since
its discovery. Flavonoids commonly found in the human diet have attracted a lot of attention …

There is controversial literature about the effects of the interleukin‐2 (IL‐2) cytokine family in
COVID‐19 pathogenesis and immunity. So we aimed to identify the potential in the role of …

Bioinformatics analysis has been playing a vital role in identifying potential genomic
biomarkers more accurately from an enormous number of candidates by reducing time and …

Concern regarding coronavirus (CoV) outbreaks has stayed relevant to global health in the
last decades. Emerging COVID-19 infection, caused by the novel SARS-CoV2, is now a …

Results Eighty-six studies were eligible to be included in the meta-analysis. For 7956
patients, the most common CT findings were bilateral pattern of involvement (78%; 95% CI …

Quercetin is an important antioxidant with high bioactivity and it has been used as SARS-
CoV-2 inhibitor significantly. Quercetin, one of the most abundant flavonoids in nature, has …

Introduction The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
has taken a toll on humans, and the development of effective vaccines has been a promising …